Rite Aid (RAD) June Comps Rose 0.7%; YTD Comps Down 1.7%
Tweet
Share
E-mailGet Alerts RAD Hot Sheet
Join SI Premium – FREE
Rite Aid Corporation (NYSE: RAD) announced sales results for June.
Monthly Sales
For the four weeks ended June 29, 2013, same store sales increased 0.7 percent over the prior-year period. June front-end same store sales increased 0.4 percent. Pharmacy same store sales, which included an approximate 305 basis points negative impact from new generic introductions, increased 0.9 percent. Prescription count at comparable stores decreased 0.2 percent over the prior-year period.
Total drugstore sales for the four-week period increased 0.2 percent to $1.927 billion compared to $1.924 billion for the same period last year. Prescription sales accounted for 67.4 percent of drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Year-to-Date
Same store sales for the 17-week period ended June 29, 2013 decreased 1.7 percent over the prior-year period. Front-end same store sales increased 0.4 percent while pharmacy same store sales decreased 2.7 percent. Prescription count at comparable stores decreased 0.1 percent over the prior-year period.
Total drugstore sales for the 17 weeks ended June 29, 2013 decreased 2.1 percent with sales of $8.191 billion compared to $8.365 billion for the same period last year. Prescription sales represented 67.5 percent of total drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Monthly Sales
For the four weeks ended June 29, 2013, same store sales increased 0.7 percent over the prior-year period. June front-end same store sales increased 0.4 percent. Pharmacy same store sales, which included an approximate 305 basis points negative impact from new generic introductions, increased 0.9 percent. Prescription count at comparable stores decreased 0.2 percent over the prior-year period.
Total drugstore sales for the four-week period increased 0.2 percent to $1.927 billion compared to $1.924 billion for the same period last year. Prescription sales accounted for 67.4 percent of drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Year-to-Date
Same store sales for the 17-week period ended June 29, 2013 decreased 1.7 percent over the prior-year period. Front-end same store sales increased 0.4 percent while pharmacy same store sales decreased 2.7 percent. Prescription count at comparable stores decreased 0.1 percent over the prior-year period.
Total drugstore sales for the 17 weeks ended June 29, 2013 decreased 2.1 percent with sales of $8.191 billion compared to $8.365 billion for the same period last year. Prescription sales represented 67.5 percent of total drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Tempus AI Inc (TEM) at Overweight
- Dell (DELL) PT Raised to $650 at Bernstein SocGen Group
- NVIDIA (NVDA) Said To Near $14 bln Deal For Hugging Face This Week - Bloomberg
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
